A Study of Volociximab in Metastatic Melanoma

NCT00369395 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient clinical activity

Conditions

Stage IV Melanoma

Interventions

DRUG: volociximab

Sponsor

Abbott

Collaborators

[object Object]